OncoSec Medical Incorporated (ONCS) |
|
2.24 0.03 (1.36%)
|
12-06 16:00 |
|
Open: |
2.22 |
Pre. Close: |
2.21 |
|
High:
|
2.2664 |
Low:
|
2.22 |
|
Volume:
|
104,980 |
Market Cap:
|
24M |
|
|
|
|
OncoSec Medical Inc is a biotechnology company engaged in designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.273 - 2.281 |
2.281 - 2.288 |
|
Low:
|
2.197 - 2.208 |
2.208 - 2.216 |
|
Close:
|
2.224 - 2.24 |
2.24 - 2.254 |
|
Technical analysis |
as of: 2019-12-06 4:37:14 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 2.86 One year: 3.34 |
| Support: |
Support1: 2.05 Support2: 1.80 |
| Resistance: |
Resistance1: 2.45 Resistance2: 2.86 |
| Pivot: |
2.06  |
| Moving Average: |
MA(5): 2.18 MA(20): 2.06
MA(100): 2.08  MA(250): 3.94 |
| MACD: |
MACD(12,26): 0.02 Signal(9): -0.01 |
| Stochastic oscillator: |
%K(14,3): 90.15 %D(3): 87.95 |
| RSI: |
RSI(14): 59.54 |
| 52-week: |
High: 9.50 Low: 1.60 Change(%): -74.5 |
| Average Vol(K): |
3-Month: 27638 10-Days: 6125 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.ONCS has closed below upper band by 6.7%. Bollinger Bands are 11.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-12-04
OncoSec Comments on Disturbing Elements of Alpha Holdings’ Revised Preliminary Proxy Filing
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, issued a statement highlighting a troubling voting scheme buried in Alpha Holdings, Inc.’s (“Alpha”) revised preliminary proxy statement filed on December 3, 2019. The relevant section is below: If we obtain a sufficient number of votes AGAINST the proposal being submitted at the Special Meeting for stockhol
2019-12-02
OncoSec Sets the Record Straight on Alpha Holdings’ False and Misleading Statements
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ: ONCS), (the “Company” or “OncoSec”) a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to shareholders. The full text of the letter and additional information can be found at www.advancingoncosec.com. December 2, 2019 Dear Fellow OncoSec Shareholders, OncoSec Medical Incorporated (“OncoSec”, the “Company”, “we” or “our”) has scheduled a Special Meeting of Shar
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Capital Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
10.67 |
| Shares Float (M) |
7.44 |
|
% Held by Insiders
|
18.21 |
|
% Held by Institutions
|
6.40 |
|
Shares Short (K)
|
245 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-4.292 |
|
Book Value (p.s.)
|
2.280 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-62.4 |
|
Return on Equity (ttm)
|
-128.3 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-2.790 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-29.00 |
|
Levered Free Cash Flow (M)
|
-16.86 |
Stock Valuations |
|
P/E
|
-0.52 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
0.98 |
|
P/S
|
|
|
P/CF
|
-0.82 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2019-05-21 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
